At age 37, Kathy Giusti was diagnosed with multiple myeloma and told she had just three years to live. Instead of accepting that fate, she turned urgency into action and founded the Multiple Myeloma Research Foundation (MMRF), transforming how cancer nonprofits accelerate drug development. Today, more than 15 therapies have been approved for multiple myeloma and survival rates have more than doubled.

In this episode of All Things Cancer, Dr. Sujuan Ba speaks with Kathy Giusti about her new book Fatal to Fearless, the leadership and strategy required to drive progress in cancer research, and how collaboration between nonprofits, academia, industry, and regulators can speed lifesaving treatments to patients.

They also explore the future of cancer research, including venture philanthropy, data sharing, AI-driven discovery, and why patients must be empowered to advocate for themselves in a complex medical system.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör National Foundation for Cancer Research. Innehållet i podden är skapat av National Foundation for Cancer Research och inte av, eller tillsammans med, Poddtoppen.